Showing results (111-120 of 120) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 120 results.
Epidemics|March 8, 2022
Recalibrating the notion of modelling for policymaking during pandemicsYot Teerawattananon, Sarin Kc, Y-Ling Chi, et al.
World Journal of Gastroenterology|March 25, 2020
Serum N-glycan markers for diagnosing liver fibrosis induced by hepatitis B virusXi Cao, Qing-Hua Shang, Xiao-Ling Chi, et al.
Gates Open Research|February 12, 2021
What next after GDP-based cost-effectiveness thresholds?Y-Ling Chi, Mark Blecher, Kalipso Chalkidou, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam|November 12, 2020
Differences in MicroRNA Expression in Chronic Hepatitis B Patients with Early Liver Fibrosis Based on Traditional Chinese Medicine SyndromesMei-Jie Shi, Huan-Ming Xiao, Yu-Bao Xie, et al.
Macromolecular Bioscience|June 6, 2023
Creation of Chitosan-Based Nanocapsule-in-Nanofiber Structures for Hydrophobic/Hydrophilic Drug Co-Delivery and Their Dressing Applications in Diabetic WoundsZheng-Ian Lin, Tzu-Hsien Tsai, Kuan-Chi Yu, et al.
Hepatobiliary Surgery and Nutrition|August 21, 2023
LEARN algorithm: a novel option for predicting non-alcoholic steatohepatitisGang Li, Tian-Lei Zheng, Xiao-Ling Chi, et al.
Chinese Journal of Integrative Medicine|September 14, 2018
Chinese Herbal Medicine Combined with Entecavir for HBeAg Positive Chronic Hepatitis B: Study Protocol for a Multi-Center, Double-Blind Randomized-Controlled TrialYong-An Ye, Xiao-Ke Li, Da-Qiao Zhou, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam|April 4, 2022
Bushen Jianpi Formula Combined with Entecavir for the Treatment of HBeAg-Negative Chronic Hepatitis B: A Multicenter, Randomized, Double-Blind, Placebo-Controlled TrialJing-Hao Zhang, Xin Zhang, Zhen-Hua Zhou, et al.
Journal of Ethnopharmacology|April 10, 2022
Efficacy and safety of AnluoHuaxian pills on chronic hepatitis B with normal or minimally elevated alanine transaminase and early liver fibrosis: A randomized controlled trialHuan-Ming Xiao, Mei-Jie Shi, Jun-Min Jiang, et al.
Chinese Journal of Integrative Medicine|January 11, 2020
Adefovir Dipivoxil plus Chinese Medicine in HBeAg-Positive Chronic Hepatitis B Patients: A Randomized Controlled 48-Week TrialXiao-Ke Li, Ming-Xiang Zhang, Feng-Zhen Shao, et al.
Pageof 12